Guide price only. Final cost is confirmed after assessment.
uFat Regenerative Therapy is a groundbreaking advancement in regenerative medicine. At London Cartilage Clinic, we utilise this cutting-edge technique, focusing on the gentle processing of adipose tissue to preserve mesenchymal Stem Cell / Medicinal Signaling Cells, enhancing the body's natural healing process. uFat therapy stands out for its ability to maintain the integrity of adipose tissue, offering superior regenerative capabilities compared to traditional methods.
Reviewed byProf Paul Lee MBBch, FRCS (Tr & Orth), PhDLast reviewed 1 May 2026
uFat focuses on gentle adipose processing to better preserve cellular architecture and stromal vascular niches that support tissue repair.
uFat and mFat are both valuable; selection depends on tissue target, required potency, and treatment objectives.
uFat is minimally invasive and designed to deliver regenerative tissue support with less disruption than more aggressive processing techniques.
At London Cartilage Clinic, uFat is integrated into a full care plan that includes diagnosis, procedural precision, and follow-up to track clinical response.
uFat therapy differs in its focus on preserving the structural integrity and cellular composition of adipose tissue. This results in a product richer in mesenchymal Stem Cell / Medicinal Signaling Cells, offering more potent regenerative properties.
uFat therapy is effective for a variety of conditions, including osteoarthritis, tissue injuries, and in cosmetic applications for tissue regeneration and anti-aging treatments.
Recovery times for uFat therapy are typically minimal, with most patients resuming normal activities within a short period. However, the specific recovery time can vary depending on the individual case.
Still have more specific concerns?
Free Discovery CallLondon Cartilage Clinic
Clinical updates, cartilage treatment guidance, and recovery-focused articles from our specialist team.
ChondroFiller lasts substantially longer — 70–85% sustain meaningful relief for three to five years versus six to twelve months for hyaluronic acid — but only because each addresses different pathology: focal cartilage defects through endogenous cell recruitment versus diffuse osteoarthritis through synovial lubrication.
The ChondroFiller injection itself takes minutes, but the regeneration it triggers spans 12–24 months as progenitor cells migrate into the collagen scaffold and gradually replace it with mature cartilage tissue.
When ChondroFiller is injected into the joint, it undergoes pH-triggered gelation; the resulting scaffold recruits the body's own repair cells whilst suppressing MMP-13, the primary cartilage-destroying enzyme.
